Skip to main content

Fiscal Wizard · Single-issue tearsheet

IRON / Jun 22, 2026 Run #7583

IRON

Disc Medicine, Inc.

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. It also develops preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. The company was founded in 2017 and is headquartered in Watertown, Massachusetts.

Composite verdict

F 25.9 / 100
Bearish setup · Reversal 4 drivers · 2 gates blocking
  • Volume Climax
  • Wedge Pattern
  • Engulfing
Consider long put target Δ ~0.60 · ~35 DTE Bearish setup, Grade B → ITM put target

Industry rank 203rd of 598 in Biotechnology

rescore-sweep
Technical synthesis
Bull 0%Evidence: Medium · 17 signals100% Bear
Momentum Neutral 45Mean-reversion Neutral 40

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

24.8 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Greenblatt ROC 76
Free Cash Flow Yield 0
Return on Capital Employed 75
EPS Growth (YoY) 0
P/B 75
Return on Equity 25

Technicals Bearish

27.0 / 100

Bearish setup leads (Volume Climax, Wedge Pattern, Engulfing); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Volume Climax 18
Wedge Pattern 24
Engulfing 24

Risk Gates

2 blocking 8 caution

2 guards active, 24 signals gated.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

Piotroski F-Score Blocking

Bottom-band Piotroski F blocks bullish signals — fundamental-quality risk.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for IRON.